English Edition. Medscape. English; Deutsch; Español; Français; Português; Univadis ...

Fifty patients without AF but undergoing cavotricuspid isthmus ablation for recurrent paroxysmal or persistent AFL were assigned to also receive or not receive same-session PVI ablation.

The second phase of the trial included the addition of studying the focal FARAPOINT™ Pulsed Field Ablation Catheter for cavotricuspid isthmus (CTI) ablation to treat typical atrial flutter, ...

Notably, instances of spasm reached 77.8% when the ablation line was situated superiorly along the mitral isthmus -- yet did not happen in any of the eight cases where the line was situated ...

Medtronic announced the FDA approval of its mapping and dual-energy catheter ablation system for the treatment of persistent atrial fibrillation and radiofrequency ablation of cavotricuspid ...

Patients who underwent radiofrequency ablation were more likely to receive cavotricuspid isthmus ablation (22.8% vs 13.7%), superior vena cava isolation (10.4% vs 4.8%), and left atrial posterior wall ...

Research conducted across 12 hospitals in China has discovered that combining linear ablation with ethanol infusion via the vein of Marshall ... mitral isthmus, and cavotricuspid isthmus.

US physicians now have access to a second pulsed-field ablation (PFA) option to treat their patients with atrial fibrillation (AF) following the US Food and Drug Administration’s approval of the ...

The Sphere-9 catheter (Medtronic) . Medtronic said its PulseSelect system, the first pulsed field ablation device approved by the FDA back in December 2023, will continue to provide a single-shot ...

Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month primary endpoint results from the second phase of the ADVANTAGE AF clinical trial evaluating the use of the FARAPULSE ...

The second phase of the trial included the addition of studying the focal FARAPOINT™ Pulsed Field Ablation Catheter for cavotricuspid isthmus (CTI) ablation to treat typical atrial flutter ...